arrow
T

Thomas F. Osborne

integrated dna technologies
H指数:17
被引数:1,591

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

UNCOVERseq enables sensitive and controlled gene editing off-target nomination across CRISPR-Cas modalities and systems

UNCOVERseq 实现了跨CRISPR-Cas模态和系统的敏感且可控的基因编辑脱靶位点鉴定

2026-08-110
OA
Veteran Mental Health Emergency Care Utilization Following SARS-CoV-2 Infection

SARS-CoV-2感染后退伍军人心理健康急诊医疗服务利用

2025-06-050
PRE
Area Deprivation Index and Melanoma Thickness in Veterans

区域剥夺指数与黑色素瘤厚度在退伍军人中

2025-06-010
PRE
Target Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post-Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras
2025-04-010
PRE
Impact of SARS-CoV-2 Infection on Long-Term Depression Symptoms among Veterans (Apr, 10.1007/s11606-024-08630-z, 2024)
2024-05-140
OA
Impact of SARS-CoV-2 Infection on Long-Term Depression Symptoms among Veterans
2024-04-164
OAAI
Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among US Veterans A Target Trial Emulation

Nirmatrelvir-ritonavir对美国退伍军人Post-COVID-19状况发展的有效性

2023-11-0117
OA
Risk of Suicide-Related Outcomes After SARS-COV-2 Infection: Results from a Nationwide Observational Matched Cohort of US Veterans
2023-10-264
PRE
Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among US Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes
2023-06-0133
OA
Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort study
2023-05-234
OA